INTERNATIONAL CONFERENCE ON ARTHROPLASTY AND ORTHOPEDIC SURGERY 21′
Last week, we had the opportunity to exhibit the results obtained in our pilot biological study at the International Conference on Arthroplasty in Vienna.
The initial results presented show the development reached so far. In these results is seen that NELA implant improves the host’s tolerability, evidences a decrease in the peri-implant granulocytic reaction (reduced fibrosis + reduced neovascularization + reduced inflammation).
In this event, we met with orthopedic surgeons specialized in hip arthroplasty, confirming the medical interest in the advantages of our technology and its benefits.